Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Exclusive agreement to produce cannabis genetics in Colombia

Clever Leaves announced its commercial agreement with US-based Praetorian Global to produce premium quality cannabis flower and downstream products from Clever Leaves cultivation facility in Colombia for distribution globally. Flower products resulting from the partnership will be available by Q2 2024 to medical cannabis patients globally, including in the European Union, the United Kingdom, and Australia.

The agreement between Clever Leaves and Praetorian will allow Clever Leaves to access new technology and genetics to complement the Company’s portfolio of products and further enable the licensing and commercialization in international markets of exclusive genetics for Clever Leaves that are strongly identified and driven by Praetorian-owned cultivation I.P.

Beginning in early-2022, Praetorian launched its genetic licensing line of business and currently has executed agreements with licensees whose total global canopy exceeds 8 million square feet. Praetorian’s genetic library is now widely considered to include not only the most flavor-forward and aesthetically pleasing but also the most production-efficient and highest-yielding genetics in the industry, particularly through its Oni Seed Co. portfolio and expertise.

Praetorian is also well-known in the U.S. and international legal cannabis communities for its products cultivated from carefully developed genetics, including through the Binske and Oni consumer-facing brands. Praetorian provides access to its intellectual property mainly through licensing agreements with exclusive partners to ensure that its brands, genetics, and products maintain efficacy and consistency across all markets. By the end of 2023, Praetorian currently expects that its products will be sold across four continents.

Under the agreement, Clever Leaves and Praetorian will select specific strains for initial trials at the Company’s Colombian cultivation, from which the R&D team at Clever Leaves will be able to further progress in its product portfolio, offering a more diverse variety of carefully characterized cannabis solutions for medicinal purposes around the world. The partnership also includes a license of know-how and procedures to jointly achieve high-quality cannabis products from Clever Leaves’ cultivation and production facilities in Colombia.

“Our partnership with Praetorian will enable us to come together and produce the best genetics through Colombia’s prime cultivation conditions and the utilization of innovative technology with support from Praetorian. We are thrilled to be working with one of the most prominent names in the U.S. cannabis industry to produce high-quality cannabis genetics, which continues to be a key priority for Clever Leaves,” said Andrés Fajardo, CEO of the Company. “We are aligned with Praetorian in our plans to grow our R&D efforts and our dedication to providing an elevated experience with the best cannabis products for patients.”

“This partnership is in line with our strategic focus of expansion and diversification across emerging international cannabis markets and sales channels, which collectively represent one of the fastest-growing segments in the industry,” said Jacob Pasternack, Founder, Chairman, and CEO of Praetorian. “We believe Clever Leaves has a unique potential to capitalize on this burgeoning opportunity.”

For more information:
Clever Leaves
[email protected]  


Publication date: